Liquidia (LQDA) EPS (Basic) Growth (3y) (2023 - 2026)
Liquidia (LQDA) EPS (Basic) Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 15.17% |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 3.18% |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 2.42% |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 12.25% |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -35.06% |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 13.47% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 36.60% |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Liquidia | 6.33 Bn | 6.05 Bn | 160.92 Mn | 62.80% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 44.81% |
| Mar 31, 2026 | 48.17% |
| Dec 31, 2025 | 58.87% |
| Sep 30, 2025 | -79.43% |
| Jun 30, 2025 | -74.18% |
| Mar 31, 2025 | -14.31% |
| Dec 31, 2024 | -28.43% |
| Sep 30, 2024 | -53.83% |
| Jun 30, 2024 | -98.29% |
| Mar 31, 2024 | -62.94% |
| Dec 31, 2023 | 3.75% |
| Sep 30, 2023 | -6.64% |
| Jun 30, 2023 | -18.76% |
| Mar 31, 2023 | 2.69% |